一个高尔基向金复合体在自调节中起着双重作用,用于高效的癌症治疗
Bing-Bing Liang1, Qian Liu2, Bin Liu1
1Key Laboratory of Bioinorganic and Synthetic Chemistry of Ministry of Education, School of Chemistry, IGCME, Sun Yat-Sen University, Guangzhou, 510275, China.
Angewandte Chemie (International ed. in English)
|September 15, 2023
概括
研究人员开发了一种新的高尔基向 (II) 复合体,Pt3,通过诱导高尔基压力和双调节自,有效消除肺癌瘤. 这一策略为癌症治疗提供了一种新的方法.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生化学
背景情况:
- 自调节是癌症治疗的一个关键策略.
- 高尔基自 (Golgiphagy) 是一个尚未探索的抗瘤途径.
- 针对戈尔吉装置提供了一个新的治疗途径.
研究的目的:
- 开发和评估一种新的高尔基向金 (II) 复合物 (Pt3) 用于癌症治疗.
- 为了研究Pt3诱导的抗瘤效应的机制.
- 探索戈尔吉应激和自调节在Pt3疗效中的作用.
主要方法:
- 金 (II) 复合物Pt3.3的合成和表征,该复合物是戈尔吉的金 (II) 目标.
- 在体外细胞毒性测试中,在肺癌细胞中比较了Pt3与思丁.
- 在内和尾静脉内给药后的体内抗瘤疗效研究.
- 分析戈尔吉结构,蛋白质表达 (GM130,GRASP65/55) 和细胞过程 (运输,糖化).
- 自流和亡试验以阐明作用机制.
主要成果:
- Pt3显示出显著更高的细胞毒性 (大约. 20x) 与西斯普拉丁相比,可以预防肺癌.
- 内注射Pt3导致了 in vivo 完全消除瘤.
- Pt3诱导了大量的戈尔吉压力,其特点是结构碎片化和蛋白质下调.
- Pt3触发了Golgiphagy,但抑制了自细胞和溶酶细胞的融合,这是自细胞的双重作用.
- 这种双重调节导致蛋白质稳定性丧失和亡性癌细胞死亡.
结论:
- Pt3是第一个 Golgi 向的复合体,可以诱导 Golgi 压力介导的自流的双重调节.
- Pt3有效地利用了自 - 亡交叉对高效的癌症治疗.
- 这种新的机制为治疗肺癌和潜在的其他癌症提供了一个有希望的新策略.
相关概念视频
Autophagy
4.3K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.3K
Delivery Pathways to the Lysosome
6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
The Proteasome
885
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
885


